792
Views
8
CrossRef citations to date
0
Altmetric
Review

Pertussis in Latin America and the Hispanic Caribbean: a systematic review

, , , , , ORCID Icon, & show all
Pages 829-845 | Received 11 Feb 2019, Accepted 10 Jul 2019, Published online: 25 Jul 2019

References

  • Tan T, Dalby T, Forsyth K, et al. Pertussis across the globe: recent epidemiologic trends from 2000 to 2013. Pediatr Infect Dis J. 2015;34:e222–e232.
  • World Health Organization. Pertussis vaccines: WHO position paper - September 2015. Wkly Epidemiol Rec. 2015;90:433–458.
  • Heininger U, Andre P, Chlibek R et al. Comparative epidemiologic characteristics of pertussis in 10 central and Eastern European countries, 2000-2013. PLoS One 2016; 11:e0155949
  • World Health Organization. Data, statistics and graphics. 3. disease incidence. 2017. [cited 2018 Feb 27]. Available from: http://www.who.int/immunization/monitoring_surveillance/data/en/.
  • World Health Organization. Data, statistics and graphics. 4. Immunization coverage or administered doses. 2017. [cited 2018 Feb 27]. Available from: http://www.who.int/immunization/monitoring_surveillance/data/en/
  • Pan American Health Organization. Division of vaccines, immunization. Expanded program on immunization. Coverage rates: DPT-3, OPV-3, measles, BCG-región of the America 2000 and 2001. PAI Bol Inf. 2002;24:7.
  • Pan American Health Organization. Division of vaccines, immunization. Expanded program on immunization. Coverage rates: DPT-3, OPV-3, measles, BCG in the region of the Americas, 1999 and 2000 (revised). PAI Bol Inf. 2001;23:7.
  • Pan American Health Organization. Division of vaccines, immunization. Expanded program on immunization. Coverage rates: DPT-3, OPV-3, measles, BCG in the Region of the Americas: 1998 and 1999. PAI Bol Inf. 2000;22:7.
  • Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–171.
  • Hosseinpoor AR, Bergen N, Schlotheuber A, et al. State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household health surveys. Lancet Glob Health. 2016;4:e617–e626.
  • Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J. 2007;26:238–242.
  • Barrantes T, Rodriguez J, Barrantes M et al. Creating a model of integrated surveillance for vaccine-preventable diseases: the Costa Rican experience. 3rd North American Congress of Epidemiology, Montreal; Quebec, Canada. Am J Epidemiol. 2011; 173 (Suppl):S28.
  • Calvo N, Morice A, Sáenz E, et al. Using surveys of schoolchildren to evaluate coverage with and opportunity for vaccination in Costa Rica. Rev Panam Salud Publica. 2004;16:118–124.
  • Herrera JF, Vargas A, Campos M, et al. Inmunofluorescencia por Bordetella pertusis hospital Nacional de Niños. Rev Méd Hosp Nac Niños (Costa Rica). 2002;37:33–39.
  • Suarez-Castaneda E, Pezzoli L, Elas M, et al. Routine childhood vaccination programme coverage, El Salvador, 2011-In search of timeliness. Vaccine. 2014;32:437–444.
  • Gloyd S, Torres JS, Mercer MA. Immunization campaigns and political agendas: retrospective from Ecuador and El Salvador. Int J Health Serv. 2003;33:113–128.
  • Phadke VK, McCracken JP, Kriss JL, et al. Clinical characteristics of hospitalized infants with laboratory-confirmed pertussis in Guatemala. J Pediatric Infect Dis Soc. 2017 Epub ahead of print.
  • DelaFuente JP, Castillo-Mazariegos EJ, Asturias EJ. Differential preference for pertussis and poliomyelitis vaccines in urban versus rural parents in Guatemala. Paediatr Child Health. 2016;21:e15–e16.
  • D’Ardenne KK, Darrow J, Furniss A, et al. Use of rapid needs assessment as a tool to identify vaccination delays in Guatemala and Peru. Vaccine. 2016;34:1719–1725.
  • Maldonado Briones H, Castillo L, Rodas J, et al. Epidemiology of bordetella pertussis infection in a Guatemalan children’s hospital (134 WSPID-0956). 9th World Congress on Pediatric Infectious Diseases (WSPID) 2015 November 18- 21, Rio De Janeiro, Brazil.
  • Delamonica E, Minujin A, Gulaid J. Monitoring equity in immunization coverage. Bull World Health Organ. 2005;83:384–391.
  • Menzies NA, Suharlim C, Geng F, et al. The cost determinants of routine infant immunization services: a meta-regression analysis of six country studies. BMC Med. 2017;15:178.
  • He Y, Zarychta A, Ranz JB, et al. Childhood immunization rates in rural Intibuca, Honduras: an analysis of a local database tool and community health center records for assessing and improving vaccine coverage. BMC Public Health. 2012;12:1056.
  • Victora CG, Fenn B, Bryce J, et al. Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys. Lancet. 2005;366:1460–1466.
  • Barham T, Maluccio JA. Eradicating diseases: the effect of conditional cash transfers on vaccination coverage in rural Nicaragua. J Health Econ. 2009;28:611–621.
  • Nieto Guevara J, Luciani K, Montesdeoca Melian A, et al. [Hospital admissions due to whooping cough: experience of the del nino hospital in Panama. Period 2001-2008]. An Pediatr (Barc). 2010;72:172–178.
  • Luis BAL, Guerrero Almeida ML, Ruiz-Palacios GM. A place for Bordetella pertussis in PCR-based diagnosis of community-acquired pneumonia. Infect Dis (Lond). 2018;50:232–235.
  • Aquino-Andrade A, Martinez-Leyva G, Merida-Vieyra J, et al. Real-time polymerase chain reaction-based detection of Bordetella pertussis in Mexican infants and their contacts: A 3-year multicenter study. J Pediatr. 2017;188(217–223):e211.
  • Perez-Perez GF, Rojas-Mendoza T, Cabrera-Gaytan DA, et al. [Pertussis in Mexico, an epidemiological overview. A study of 19 years at the instituto Mexicano del Seguro social]. Rev Med Inst Mex Seguro Soc. 2015;53:164–170.
  • Villarreal-Perez JZ, Ramirez-Aranda JM, Rodriguez-Rodriguez I, et al. Absence of antibodies against Bordetella pertussis in pregnant women and newborns in the state of Nuevo Leon. J Perinat Med. 2014;42:649–654.
  • Varan AK, Esteves-Jaramillo A, Richardson V, et al. Intention to accept Bordetella pertussis booster vaccine during pregnancy in Mexico City. Vaccine. 2014;32:785–792.
  • Ochoa-Perez UR, Hernandez-Sierra JF, Escalante-Padron FJ, et al. Epidemiology of Bordetella pertussis in San Luis Potosi, Mexico. Pediatr Infect Dis J. 2014;33:540–542.
  • Conde-Glez C, Lazcano-Ponce E, Rojas R, et al. Seroprevalence of Bordetella pertussis in the Mexican population: a cross-sectional study. Epidemiol Infect. 2014;142:706–713.
  • Sandoval PT, Arreola Ldel P, Quechol GR, et al. [Bordetella pertussis in adolescent students in Mexico City]. Rev Saude Publica. 2008;42:679–683.
  • Gutiérrez-Trujillo G, Pérez-Enríquez LR, González-García A, et al. Enfermedades inmunoprevenibles. Coberturas e Impactos de la vacunación. Rev Med Inst Mex Seguro Soc. 2006;44(Suppl 1):S97–S109.
  • Jurado Hernandez VH, Sanchez-Casillas JL, Vo P, et al. The short-term economic impact of childhood preventive health programs in Mexico. Value Health. 2014;17(3):A172–A173.
  • Reyna Figueroa J, Vidal Vazquez P, Lopez-Collada VR. [Epidemiology of pentavalent acellular vaccine-preventable diseases in Mexico]. Vacunas. 2013;14:62–68.
  • Mendoza-Flores L, Palau-Davila L, Garza-gonzalez E et al. Epidemiological and clinical data of Bordetella pertussis infection among children younger than one-year-old treated in a university hospital in Northern Mexico. Infectious Diseases Society of America: IDSA 2016; IDWeek 2016TM New Orleans; 2016 October 26-30; LA
  • Cardona D, Garzon MO, Calle M, et al. [Trends in pertussis mortality and morbidity in Colombia, 2002-2012]. Biomedica. 2016;36:397–405.
  • Sarmiento JD, Villada F, Orrego JC, et al. Adverse events following immunization in patients with primary immunodeficiencies. Vaccine. 2016;34:1611–1616.
  • Mosquera PA, Hernandez J, Vega R, et al. The impact of primary healthcare in reducing inequalities in child health outcomes, Bogota-Colombia: an ecological analysis. Int J Equity Health. 2012;11:66.
  • Mosquera PA, Hernandez J, Vega R, et al. Primary health care contribution to improve health outcomes in Bogota-Colombia: a longitudinal ecological analysis. BMC Fam Pract. 2012;13:84.
  • Villegas D, Echandia-Villegas CA, Echandia CA. Afebrile pneumonia (whooping cough) syndrome in infants at hospital Universitario del Valle, Cali, 2001-2007. Colomb Med (Cali). 2012;43:114–118.
  • Montilla-Escudero EA, Rojas-Baquero F, Ulloa-Virguez AP. [Correlation among the DIF, PCR and ELISA techniques for determining the frequency of Bordetella parapertussis and Bordetella pertussis in an outbreak of whooping cough in the department of Antioquia, Colombia, 2013.]. Infectio. 2016;20:138–150.
  • Astudillo M, Estrada VE, de Soto MF, et al. [Bordetella pertussis infection in household contacts of cases of pertussis in the southeast zone of the city of Cali,Colombia, 2006-2007]. Colomb Med. 2011;42:184–190.
  • De La Hoz F, Alvis N, Moreno J, et al. Cost-effectiveness analysis of the introduction of acellular pertussis in Colombian adolescents. Value Health. 2011;14(3):A118.
  • Narváez J, Osorio MB, Castañeda-Orjuela C, et al. Is Colombia reaching the goals on infant immunization coverage? A quantitative survey from 80 municipalities. Vaccine. 2017;35:1501–1508.
  • Ulloa Virgüe AP. Pertussis epidemiological behavior in Colombia. Revista Cubana De Medicina General Integral. 2015;31:42–51.
  • De La Hoz F, Perez L, Wheeler JG, et al. Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage? Trop Med Int Health. 2005;10:322–329.
  • Morón Duarte LS, Moreno J, Gracia M, et al. Estado de portadores de Bordetella pertussis en adolescentes de 12 a 19 años en el departamento del Tolima, Colombia, 2007. Investigaciones Andina. 2008;10:7–26.
  • Velásquez M, Moreno GC, Romero SL, et al. Factores de riesgo asociados a complicaciones por Bordetella pertussis en la Fundación Hospital de la Misericordia, 2009-2013. Infectio. 2015;19:101–108.
  • Villareal C, Buelvas D, Morón L, et al. Brote de tosferina, municipio de sincelejo departamento de sucre, Colombia, 2008. Investigaciones Andina. 2008;10:86–95.
  • Cruz LF, Giron LN, Velasquez R, et al. Coberturas de vacunación en el Valle del Cauca, 2002. Colomb Med (Cali). 2003;34:17–23.
  • Morón-Duarte L, Espitia MT. Evaluación rápida de coberturas vacunales en Bogotá, 2006. Rev Salud Pública. 2009;11:237–246.
  • Morón Duarte LS. Enfermedades inmunoprevenibles vigilancia en salud pública de la tos ferina en Colombia, 2005. Inf Quinc Epidemiol Nac. 2006;11:73–77.
  • Hoest C, Seidman JC, Lee G, et al. Vaccine coverage and adherence to EPI schedules in eight resource poor settings in the MAL-ED cohort study. Vaccine. 2017;35:443–451.
  • Bailon H, Leon-Janampa N, Padilla C, et al. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Peru, 2012. BMC Infect Dis. 2016;16:422.
  • Pavic-Espinoza I, Bendezu-Medina S, Herrera-Alzamora A, et al. High prevalence of Bordetella pertussis in children under 5 years old hospitalized with acute respiratory infections in Lima, Peru. BMC Infect Dis. 2015;15:554.
  • Del Valle-Mendoza J, Casabona-Ore V, Petrozzi-Helasvuo V, et al. Bordetella pertussis diagnosis in children under five years of age in the regional hospital of Cajamarca, Northern Peru. J Infect Dev Ctries. 2015;9:1180–1185.
  • Castillo ME, Bada C, Del Aguila O, et al. Detection of Bordetella pertussis using a PCR test in infants younger than one year old hospitalized with whooping cough in five Peruvian hospitals. Int J Infect Dis. 2015;41:36–41.
  • Ochoa TJ, Zea-Vera A, Bautista R, et al. Vaccine schedule compliance among very low birth weight infants in Lima, Peru. Vaccine. 2015;33:354–358.
  • Zerpa R, Ore E, Quispe C, et al. Lophomonas sp. In respiratory tract secretions in hospitalized children with pneumonia and Bordetella pertussis co-infection. Am J Trop Med Hyg. 2013;1:419.
  • Vargas Herrera J, Carrera Palao RE, Yarleque Dioses V, et al. [DTP vaccine and interstitial pneumonitis in infants dying in Lima (Peru) in 2001 and 2002.]. Vacunas. 2007;8:173–181.
  • Suárez Moreno V, Hernández Díaz HR. Pertusis. Módulos Técnicos Serie De Documentos Monográficos. 2000;6:43.
  • Verhagen LM, Warris A, Hermans PWM, et al. High prevalence of acute respiratory tract infections among Warao Amerindian children in venezuela in relation to low immunization coverage and chronic malnutrition. Pediatr Infect Dis J. 2012;31:255–262.
  • Farías Z, Rodríguez C, Marcano D, et al. Estudio comparativo de la sensibilidad entre el cultivo y la reacción en cadena de la polimerasa para la detección de Bordetella pertussis a partir de muestras de hisopado nasofaríngeo. Rev Inst Nacional Higiene “Rafael Rangel”. 2015;46:38–50.
  • Cardozo MA, Gaiti J, López MG. Conocimiento del personal de salud sobre la tos ferina y su prevención por vacunas. Arch Venez Pueric Pediatr. 2012;75:11–15.
  • David A, Kouris E, Álvarez M, et al. Bordetella pertussis: caracterización epidemiológica y diagnóstico. Arch Venez Pueric Pediatr. 2005;68:164–169.
  • Sebastián MS, Goicolea I, Avilés J, et al. Improving immunization coverage in rural areas of Ecuador: A cost-effectiveness analysis. Trop Doct. 2001;31:21–24.
  • Bosch JJ, Fernandez H, Polak FP, et al. Seroprevalence of Bordetella pertussis among vaccinated and unvaccinated pregnant women and newborn infants in a university hospital of Buenos Aires. Arch Argent Pediatr. 2017;115:311–315.
  • Giayetto VO, Blanco S, Mangeaud A, et al. [Features of Bordetella pertussis, Bordetella spp. infection and whopping cough in Cordoba province, Argentina]. Rev Chilena Infectol. 2017;34:108–115.
  • Lavayen S, Zotta C, Cepeda M, et al. [Infection by Bordetella pertussis and bordetella parapertussis in cases of suspected whooping cough (2011-2015) in Mar del Plata, Argentina]. Rev Peru Med Exp Salud Publica. 2017;34:85–92.
  • Vizzotti C, Juarez MV, Bergel E, et al. Impact of a maternal immunization program against pertussis in a developing country. Vaccine. 2016;34:6223–6228.
  • Kusznierz G, Schmeling F, Cociglio R, et al. [Epidemiologic and clinical characteristics of children with disease due to Bordetella pertussis in Santa Fe, Argentina]. Rev Chilena Infectol. 2014;31:385–392.
  • Romanin V, Agustinho V, Califano G, et al. Epidemiological situation of pertussis and strategies to control it: argentina, 2002-2011. Arch Argent Pediatr. 2014;112:413–420.
  • Moreno L, Montanaro P, Bujedo E, et al. [Pertussis predictors in hospitalized infants with acute lower respiratory tract infection]. Rev Fac Cien Med Univ Nac Cordoba. 2013;70:63–69.
  • Gentile A, Salgueiro AL, Garcia Bournissen F, et al. Cost of Bordetella pertussis illness in tertiary hospitals in Argentina. Arch Argent Pediatr. 2013;111:295–302.
  • Bottero D, Griffith MM, Lara C, et al. Bordetella holmesii in children suspected of pertussis in Argentina. Epidemiol Infect. 2013;141:714–717.
  • Taffarel P, Bonetto G, Haimovich A. [Severe pertussis, progression and exchange transfusion as an alternative treatment. Case reports]. Arch Argent Pediatr. 2012;110:327–330.
  • von Specht M, Grenon S, Tagliaferri P, et al. [Whooping cough: clinical and epidemiological characteristics of 20 confirmed cases of the paediatric hospital of Misiones province]. Arch Argent Pediatr. 2009;107:449–452.
  • Riva Posse CA, Miceli IN. [Pertussis: its evolution in Argentina at the end of the twentieth century]. Medicina (B Aires). 2005;65:7–16.
  • Sevilla ME. Vaccination in pregnancy: tetanus diphtheria and acellular pertussis (Tdap) immunization strategy at hospital general de Ninos Dr Pedro de Elizalde 2013. Trop Med Int Health. 2015;20:278.
  • Dayan GH, Orellana LC, Forlenza R, et al. Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002. Rev Panam Salud Publica. 2004;16:158–167.
  • Fallo A, Manonelles G, Hozbor D, et al. Estudio de seroprevalencia de coqueluche en adultos jóvenes, mujeres en puerperio inmediato y sangre del cordón umbilical. Arch Argent Pediatr. 2014;112:315–322.
  • Gentile Á, Romanin VS, Juárez M, et al. Epidemiología de Bordetella pertussis en un hospital pediátrico. Arch Argent Pediatr. 2014;112:26–32.
  • Ruvinsky S, Mónaco A, Perez G, et al. Análisis de factores de riesgo de gravedad de la coqueluche en un hospital pediátrico. Med Infant. 2008;15:307–311.
  • Romanin V, Salvay MC, Man C, et al. Brote de Bordetella pertussis en un hospital pediátrico. Rev Hosp Niños BAires. 2005;47:211–216.
  • Romano F. Brote de coqueluche en Esquel. Arch Argent Pediatr. 2002;100:11–18.
  • Agosti MR, Gatti B, Morales JCD, et al. Reemergencia de la tos convulsa. Ludovica Pediátr. 2001;3:85–89.
  • Gentile A, Martinez AC, Lucion MF et al. Bordetella Pertussis (Bp): impact of pregnancy Tdap vaccination strategy in a pediatric hospital. Times series study. 2003-2016 (Abs 712). Infectious Diseases Society of America: IDSA 2016; IDWeek 2016TM New Orleans; 2016 October 26-30; LA. Available at: http://www.idsociety.org/Meetings.aspx
  • Katz N, Neyro S, Carrega MEP et al. Maternal Immunization in Argentina: the importance of a safety profile analysis (Abs 735). Infectious Diseases Society of America: IDSA 2016; IDWeek 2016TM New Orleans; 2016 October 26-30; LA. Available at: http://www.idsociety.org/Meetings.aspx
  • Neyro S, Katz N, Perez Carrega ME et al. Maternal immunization in Argentina. A national strategy to prevent infants morbidity and mortality (063 WSPID-0678). 9th World Congress on Pediatric Infectious Diseases (WSPID); 2015; November 18- 21; Rio De Janeiro, Brazil.
  • Russell LB, Pentakota SR, Toscano CM, et al. What pertussis mortality rates make maternal acellular pertussis immunization cost-effective in low- and middle-income countries? A Decision Analysis. Clin Infect Dis. 2016;63:S227–S235.
  • Cavaca AG, Emerich TB, Vasconcellos-Silva PR, et al. Diseases neglected by the media in Espirito Santo, Brazil in 2011-2012. PLoS Negl Trop Dis. 2016;10:e0004662.
  • Novaes ML, de Almeida RM, Bastos RR. Assessing vaccine data recording in Brazil. Rev Bras Epidemiol. 2015;18:745–756.
  • Sartori AMC, de Soarez PC, Fernandes EG, et al. Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil. Vaccine. 2016;34:1531–1539.
  • Guimaraes LM, Carneiro EL, Carvalho-Costa FA. Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data. BMC Infect Dis. 2015;15:442.
  • Mancaneira JF, Benedetti JR, Zhang L. Hospitalizations and deaths due to pertussis in children from 1996 to 2013. J Pediatr (Rio J). 2016;92:40–45.
  • Cunegundes KS, de Moraes-Pinto MI, Takahashi TN, et al. Bordetella pertussis infection in paediatric healthcare workers. J Hosp Infect. 2015;90:163–166.
  • Torres RS, Santos TZ, Torres RA, et al. Resurgence of pertussis at the age of vaccination: clinical, epidemiological, and molecular aspects. J Pediatr (Rio J). 2015;91:333–338.
  • Pimentel AM, Baptista PN, Ximenes RA, et al. Pertussis may be the cause of prolonged cough in adolescents and adults in the interepidemic period. Braz J Infect Dis. 2015;19:43–46.
  • Berezin EN, de Moraes JC, Leite D, et al. Sources of pertussis infection in young babies from Sao Paulo State, Brazil. Pediatr Infect Dis J. 2014;33:1289–1291.
  • Vaz-de-Lima LR, Martin MD, Pawloski LC, et al. Serodiagnosis as adjunct assay for pertussis infection in Sao Paulo, Brazil. Clin Vaccine Immunol. 2014;21:636–640.
  • Druzian AF, Brustoloni YM, Oliveira SM, et al. Pertussis in the central-west region of Brazil: one decade study. Braz J Infect Dis. 2014;18:177–180.
  • Ferronato AE, Gilio AE, Vieira SE. Respiratory viral infections in infants with clinically suspected pertussis. J Pediatr (Rio J). 2013;89:549–553.
  • Cunha MP, Dorea JG, Marques RC, et al. Vaccine adverse events reported during the first ten years (1998-2008) after introduction in the state of Rondonia, Brazil. Biomed Res Int. 2013;2013:853083.
  • Flannery B, Samad S, de Moraes JC, et al. Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil’s national immunization program. Vaccine. 2013;31:1523–1528.
  • Surkan PJ, Kiihl SF, Kozuki N, et al. Social support of low-income Brazilian mothers related to time to completion of childhood vaccinations. Hum Vaccin Immunother. 2012;8:596–603.
  • Baptista PN, Magalhaes VS, Rodrigues LC. The role of adults in household outbreaks of pertussis. Int J Infect Dis. 2010;14:e111–e114.
  • Trevizan S, Coutinho SE. [Epidemiological profile of pertussis in Rio Grande do Sul State, Brazil: a study of the correlation between incidence and vaccine coverage]. Cad Saude Publica. 2008;24:93–102.
  • Martins RM, Camacho LA, Lemos MC, et al. Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian national immunizations program. J Pediatr (Rio J). 2007;83:523–528.
  • Freitas FR, Sato HK, Aranda CM, et al. [Adverse events following diphtheria, pertussis and tetanus vaccinations and factors associated with severity]. Rev Saude Publica. 2007;41:1032–1041.
  • de Araujo TM, de Carvalho PM, Vieira RD. [Analysis of after-vacination side-effects occurred in Teresina]. Rev Bras Enferm. 2007;60:444–448.
  • Baptista PN, Magalhaes VS, Rodrigues LC. Children with pertussis inform the investigation of other pertussis cases among contacts. BMC Pediatr. 2007;7:21.
  • Baptista PN, Magalhaes V, Rodrigues LC, et al. Pertussis vaccine effectiveness in reducing clinical disease, transmissibility and proportion of cases with a positive culture after household exposure in Brazil. Pediatr Infect Dis J. 2006;25:844–846.
  • Da Cruz MG. [Comparative study of some health indicators in municipalities of the state of Sao Paulo in accordance to the implementation of the family health program]. Rev Esc Enferm USP. 2005;39:28–35.
  • Barata RB, de Moraes JC, Antonio PR, et al. [Immunization coverage survey: empirical assessment of the cluster sampling method proposed by the World Health Organization]. Rev Panam Salud Publica. 2005;17:184–190.
  • de Moraes Jde C, Barata R, Ribeiro MC, et al. [Vaccination coverage in the first year of life in 4 cities of the state of Sao Paulo, Brazil]. Rev Panam Salud Publica. 2000;8:332–341.
  • Saraiva FO, Minamisava R, Vieira MADS, et al. Vaccination coverage and compliance with three recommended schedules of 10-valent pneumococcal conjugate vaccine during the first year of its introduction in Brazil: A cross-sectional study. PLoS ONE. 2015;10:6. no pagination.
  • Sato APS, Waldman EA, De RFVL, et al. Safety profile of vaccines using an e-health system, Araraquara, Brazil. Eur J Epidemiol. 2015;30(8):944.
  • Amato Vieira R, Jurfest Rivero Ceccon ME, Brunow De Carvalho W. Viral respiratory infections in hospitalized newborns with clinically suspected pertussis in Sao Paulo, Brazil. J Perinatal Med. 2015:43;P–0171.
  • Fernandes AR, Martins RM, De Carvalho SMD et al. Neurological adverse events following immunization (AEFI): brazilian data. 11th European Paediatric Neurology Society Congress 19; 2015; EPNS 2015, Vienna, Austria. Eur J Paediatr Neurol. 2015;19:S72–S73.
  • Bellettini CV, de Oliveira AW, Tusset C, et al. [Clinical, laboratorial and radiographic predictors of Bordetella pertussis infection]. Rev Paulista Pediatria. 2014;32:292–298.
  • Branco FLCC, Pereira TM, Delfino BM, et al. Socioeconomic inequalities are still a barrier to full child vaccine coverage in the Brazilian Amazon: A cross-sectional study in Assis Brasil, Acre, Brazil. Int J Equity Health. 2014;13:1. no pagination.
  • Fernandes RA, Haas LC, Takemoto M, et al. Pertussis in Brazilian children: mortality, length of stay, and costs in hospitalized patients. Value Health. 2013;16(7):A348.
  • Guerreiro J, Neto EL, Pinho I, et al. Evaluation of tetravalent vaccine coverage in children under the age of one. Brazil, 2007 to 2010. Eur J Epidemiol. 2012;1:S108.
  • Leite D, Blanco RM, de Melo LCV, et al. Implementation and assessment of the use of real-time PCR in routine diagnosis for Bordetella pertussis detection in Brazil. Arch Pediatr Infect Dis. 2014;2:196–202.
  • Novaes MLO, Almeida RMV, Bastos RR, et al. Wastage of diphtheria, tetanus, pertussis and haemophilus influenzae type-b vaccine (tetravalent vaccine) and its impact on the increase of dose costs. Pan Am Health Care Exchanges. 2011;140–143. DOI:10.1109/PAHCE.2011.5871866
  • Fernandes GC, Camacho LAB, Sá Carvalho M. Surveillance system of vaccine adverse events and local data analysis - The experience in a middle-sized city in Brazil, 1999-2001. Vaccine. 2005;23:2349–2353.
  • Santos B, Bischoff AR, Chikota C, et al. Coqueluche em crianças menores de 3 anos de idade hospitalizadas em 2011 e 2012. Clin Biomed Res. 2015;35:227–232.
  • Willemann MCA, Goes FCS, Araújo ACM, et al. Adoecimento por coqueluche e número de doses administradas de vacinas Pertussis: estudo de caso-controle. Epidemiol Serv Saúde. 2014;23:207–214.
  • Silva F, Navarro M, Pinto LALT, et al. An overview of pertussis reemergence and evidence of ITS resurgence in Brazil. Rev Patol Trop. 2014;43:151–162.
  • Teixeira A, Domingues CMAS. Monitoramento rápido de coberturas vacinais pós-campanhas de vacinação no Brasil: 2008, 2011 e 2012. Epidemiol Serv Saúde. 2013;22:565–578.
  • Paulo S. Secretaria da Saúde. Informe técnico coqueluche – 2011: atualização da situação epidemiológica. ddtr/cveW2011; 1–12
  • Monteiro SAMG, Takano OA, Waldman EA. Avaliação do sistema Brasileiro de vigilância de eventos adversos pós-vacinação. Rev Bras Epidemiol. 2011;14:361–371.
  • Paiva T. A situação vacinal das crianças que apresentaram eventos adversos com vacina tetravalente no município de Belém-PA, 2008. Dissertação. 2011. Available from: http://bvssp.icict.fiocruz.br/lildbi/docsonline/get.php?id=2773
  • Mello MLR, Moraes JC, Barbosa HA, et al. Participação em dias nacionais de vacinação contra poliomielite: resultados de inquérito de cobertura vacinal em crianças nas 27 capitais brasileiras. Rev Bras Epidemiol. 2010;13:278–288.
  • Paulo S. Secretaria da Saúde. Coordenação de Vigilância em S. Coqueluche: vigilância epidemiológica e triagem diagnóstica. Boletim Imformativo. 2009;2:1–9.
  • Oliveira E Silva R, Lemes-Marques EG, Medeiros MIC, et al. Diagnóstico laboratorial da coqueluche: freqüência do isolamento de Bordetella pertussis de amostras clínicas, por meio da técnica de cultura realizada nos laboratórios regionais do Instituto Adolfo Lutz, São Paulo, Brasil. Rev Inst Adolfo Lutz. 2007;66:194–200.
  • de Jesus DM, Bastos MA, Carvalho EC. Estudo dos eventos adversos provocados pela vacina tetravalente. R Enferm UERJ. 2004;12:299–305.
  • Queiroz IT, Gomes M, Rosa G et al. Epidemiological profile of children infected with Bordetella pertussis at Varela Santiago Children’s Hospital: a retrospective study. Infectious Diseases Society of America: IDSA 2017; IDWeek 2017TM San Diego; 2017 October 4-8; CA.
  • Leite D, Martins LM, Pereira JC, et al. Pertussis diagnosis methods: culture, real-time PCR and serology - Sao Paulo, Brazil (020 WSPID-0687). 9th World Congress on Pediatric Infectious Diseases (WSPID); 2015 November 18- 21; Rio De Janeiro, Brazil.
  • Oliveira JC, Mimica MJ, Berezin EN, et al. Comparison of PCR and culture for detection of Bordetella pertussis in samples of upper respiratory tract in children hospitalized in a Brazil quaternary care hospital (143 WSPID-0415). 9th World Congress on Pediatric Infectious Diseases (WSPID); 2015 November 18- 21; Rio De Janeiro, Brazil.
  • Tauil M. Cobertura vacinal e fatores associados à vacinação incompleta em município de médio porte, Estado de São Paulo, Brasil. Dissertação. 2017:1–106. Available from: http://www.teses.usp.br/teses/disponiveis/6/6132/tde-25042017-140059/
  • Porto MA, Santos CP, Gonçalves GG, et al. Análise das desigualdades socioeconômicas na cobertura da vacina contra difteria, tétano e coqueluche (DTP)/tetravalente para menores de 1 ano de idade no Rio Grande do Sul, 2000-2009*. Epidemiol Serv Saúde. 2013;22:579–586.
  • Buchalla CM, Waldman EA, Laurenti R. A mortalidade por doenças infecciosas no início e no final do século XX no Município de São Paulo. Rev Bras Epidemiol. 2003;6:335–344.
  • Monteiro CA, Junior IF, Conde WL. [Secular trends in maternal and child health care in S. Paulo city, Brazil(1984-1996).]. Rev Saúde Pública. 2000;34(Supl 6):19–25.
  • Lima M, Estay SA, Fuentes R, et al. Whooping cough dynamics in Chile (1932-2010): disease temporal fluctuations across a north-south gradient. BMC Infect Dis. 2015;15:590.
  • Miranda C, Wozniak A, Castillo C, et al. [Presence of Bordetella holmesii in an outbreak of pertussis in Chile]. Rev Chilena Infectol. 2013;30:237–243.
  • Perret C, Viviani T, Pena A, et al. [Source of infection in young infants hospitalized with Bordetella pertussis]. Rev Med Chil. 2011;139:448–454.
  • Abarca VK, Cerda LJ, Ferreccio RC. [Adverse reactions to diphtheria-pertussis-tetanus vaccine in the Chilean Immunization Program]. Rev Med Chil. 2009;137:10–17.
  • Galleguillos B, Rubilar P. Tos ferina: una enfermedad que resurge en Chile. Vigía (Santiago). 2012;13:46–49.
  • Chile. Ministerio de Salud. Departamento de Estadísticas e Información en Salud. Departamento de I: metodología y cálculo cobertura de inmunizaciones años 2005-2010. Metodología y Cálculo Programa Nacional de Inmunizaciones 2011; 1–20
  • Olea Normandin AM. Tos Ferina. Vigía (Santiago). 2005;8:46–48.
  • Donoso FA, Wegner AA, León BJ, et al. Coqueluche en niños menores de seis meses de vida. Rev Chil Pediatr. 2001;72:334–339.
  • Almada C, Mara P, Perdomo V, et al. Tos convulsa: brote epidémico 2011-2012, Hospital Las Piedras: características clínico-evolutivas de los pacientes hospitalizados. Rev Méd Del Uruguay. 2015;31:265–271.
  • Sosa M, Castro M, Salomón S, et al. Características epidemiológicas y clínicas de niños hospitalizados con tos convulsa durante el 2012 en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell. Archivos de Pediatría del Uruguay. 2014;85:10–17.
  • González Arias M, Dall'Orso P, Cantiran E, et al. Tos convulsa: estudio clínico y de laboratorio de una enfermedad reemergente en lactantes pequeños y adolescentes. Rev Méd Urug. 2010;26:154–160.
  • Quian Rivero JW, Cerisola Cardozo A, Russomano Olivera F, et al. Infecciones por Bordetella pertussis en niños menores de un año hospitalizados y sus contactos del hogar. Arch Pediatr Urug. 2006;77:229–236.
  • Acosta E, Vignolo J, Repetto M, et al. Cobertura de vacunas en niños menores de seis años, internados en el Servicio “B” de Pediatría del Centro Hospitalario Pereira Rossell de mayo a junio del 2000. Arch Pediatr Urug. 2004;75:220–223.
  • Galindo Santana BM, Concepcion D, Galindo MA, et al. Vaccine-related adverse events in Cuban children, 1999-2008. MEDICC Rev. 2012;14:38–43.
  • Galindo Santana BM, Concepción Díaz D, Galindo Sardiña MA. Hypotonic-hyporesponsive episodes after the application of vaccines in Cuba during the period 2012-2013. Rev Cubana Med Trop. 2015;67(3).
  • Mantilla Díaz T, Ramos Gómez L, Samper Muarrak H, et al. Síndrome coqueluchoide infeccioso. Mediciego. 2006:12(1).
  • Solano R, Masa-Calles J, Garib Z, et al. Epidemiology of pertussis in two Ibero-American countries with different vaccination policies: lessons derived from different surveillance systems. BMC Public Health. 2016;16:1178.
  • Garib Z, Vargas AL, Trumbo SP, et al. Missed opportunities for vaccination in the dominican republic: results of an operational investigation. Biomed Res Int. 2016;2016;4721836.
  • Rivera A, Orengo JC, Rivera AL, et al. Impact of vaccine shortage on diphtheria and tetanus toxoids and acellular pertussis vaccine coverage rates among children aged 24 months–puerto Rico, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:667–668.
  • Arlant LHF, de Colsa A, Flores D, et al. Pertussis in Latin America: epidemiology and control strategies. Expert Rev Anti Infect Ther. 2014;12:1265–1275.
  • Pinell-McNamara VA, Acosta AM, Pedreira MC, et al. Expanding pertussis epidemiology in 6 Latin America countries through the Latin American pertussis project. Emerg Infect Dis. 2017;23 (Suppl 1):S94–S100.
  • World Health Organization. WHO-recommended surveillance standard of pertussis. 2017. [cited 2018 Apr 24]. Available from: http://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/passive/pertussis_standards/en/
  • Centers for Disease Control and Prevention. Pertussis in Argentina. 2017. [cited 2018 Apr 24]. Available from: https://www.cdc.gov/pertussis/countries/lapp-argentina.html
  • Centers for Disease Control and Prevention. Pertussis in Brazil. 2017. [cited 2018 Apr 24]. Available from: https://www.cdc.gov/pertussis/countries/lapp-brazil.html
  • Centers for Disease Control and Prevention. Pertussis in Chile. 2017. [cited 2018 Apr 24]. Available from: https://www.cdcg.ov/pertussis/countries/lapp-chile.html
  • Centers for Disease Control and Prevention. Pertussis in Colombia. 2017. [cited 2018 Apr 24]. Available from: https://www.cdc.gov/pertussis/countries/lapp-colombia.html
  • Centers for Disease Control and Prevention. Pertussis in Panama. 2017. [cited 2018 Apr 24]. Available from: https://www.cdc.gov/pertussis/countries/lapp-panama.html
  • World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2017 global summary. 2018. [cited 2018 Apr 24]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/schedules
  • Ministerio de salud Panamá. República de Panamá ministerio de salud-dirección general de salud departamento de epidemiología. 2018. [cited 2018 Apr 24]. Available from: http://www.minsa.gob.pa/
  • Ulloa-Gutierrez R, Hozbor D, Avila-Aguero ML et al. The global pertussis initiative: meeting report from the regional Latin America meeting, Costa Rica, 5-6 December, 2008. Hum Vaccin 2010; 6:876–880
  • Subsecretaria de Salud Publica Chile. Inmunizacion programatica contra difteria, tetanos, tos covulsiva, hepatitis B, poliomielitis y las enfermedades invasoras causadas por haemophilius influenzae tipo B en ninos y ninas menores de anos. 2018. [cited 2018 Nov 6]. Available from: http://vacunas.minsal.cl/wp-content/uploads/2018/01/Circular-Inmunizacion-N-1-incorporacion-hexavalente.pdf
  • Ministerio de Salud (Costa Rica). Norma Nacional Vacunación. 2013. [cited 2018 Aug 2]. Available from: https://www.ministeriodesalud.go.cr/indexphp/vigilancia-de-la-salud/normas-protocolos-y-guias/2302-norma-nacional-de-vacunacion-2013/file
  • Pan American Health Organization (PAHO). Semana de Vacunación en las Américas destaca la importancia de inmunizarse contra enfermedades prevenibles. 2014. [cited 2018 Aug 2]. Available from: https://www.paho.org/els/indexphp?option=com_content&view=article&id=905:semana-de-vacunacion-en-las-americas-destaca-la-importancia-de-inmunizarse-contra-enfermedades-prevenibles&Itemid=291
  • Centers for Disease Control and Prevention. Pertussis in Mexico. 2017. [cited 2018 Apr 24]. Available from: https://www.cdc.gov/pertussis/countries/lapp-mexicohtml
  • Vizzotti C, Neyro S, Katz N, et al. Maternal immunization in Argentina: A storyline from the prospective of a middle income country. Vaccine. 2015;33:6413–6419.
  • Ministerio de Salud Pública (Uruguay). Comunicado a personal de salud. Vacunación con dpaT a embarazadas. 2015. [cited 2018 Aug 2]. Available from: http://www.msp.gub.uy/sites/default/files/archivos_adjuntos/comunicado%20dpta%20embarazadas%202015docx.pdf
  • Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin S, Orenstein W, Offit PA, et al., editors. Plotkin’s vaccines. Seventh ed. Philadelphia, PA: Elsevier; 2018. p. 711–761.
  • Ministerio de salud Panamá. Manual de normas y procedimientos del programa ampliado de inmunizaciones. 2012. [citeed 2018 Apr 25]. Available from: http://www.minsa.gob.pa/sites/default/files/programas/folleto_normas.pdf
  • World Health Organization. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85:385–400.
  • Subaiya S, Dumolard L, Lydon P, et al. Global routine vaccination coverage, 2014. MMWR Morb Mortal Wkly Rep. 2015;64:1252–1255.
  • Pan American Health Organization (PAHO). Vaccine coverage tables. 2018. [cited 2018 Sept 21]. Available from: http://ais.paho.org/imm/IM_JRF_COVERAGE.asp
  • European Centre for Disease Control. Pertussis. 2016. [cited 2018 Sept 21]. Available from: https://ecdc.europa.eu/sites/portal/files/documents/Pertussis%20AER.pdf
  • Clarke MF, Rasiah K, Copland J, et al. The pertussis epidemic: informing strategies for prevention of severe disease. Epidemiol Infect. 2013;141:463–471.
  • Domenech de Celles M, Magpantay FMG, King AA, et al. The impact of past vaccination coverage and immunity on pertussis resurgence. Sci Transl Med. 2018;10;eaaj1748.
  • Ministerio de salud Panamá. República de Panamá, Ministerio de Salud-Dirección General de Salud, Departamento de Epidemiología Boletín Epidemiológico de Tos ferina (Boletín final 2014). 2015. [cited 2018 Apr 25]. Available from: http://www.minsa.gob.pa/sites/default/files/publicacion-general/boletin_tos_ferina_2014.pdf
  • Smallridge WE, Rolin OY, Jacobs NT, et al. Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis. 2014;209:1981–1988.
  • Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014;111:787–792.
  • Domenech de Celles M, Magpantay FM, King AA, et al. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci. 2016;283:20152309.
  • Folkhälsomyndigheten. Pertussis surveillance in Sweden: nineteen-year report. 2017. [cited 2019 Mar 11]. Available from: https://www.folkhalsomyndigheten.se/contentassets/65ed8f6dbdab4999bc358fcd9b657e77/pertussis-sweden-nineteen-year-report.pdf
  • Riesgo de convulsiones por uso de vacunas de células enteras contra la tos ferina, o contra el sarampión, la parotiditis y la rubéola. Rev Panam Salud Publica. 2001;10:181.
  • Maertens K, Cabore RN, Huygen K, et al. Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study. Vaccine. 2016;34:142–150.
  • Halperin SA, Langley JM, Ye L, et al. A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response. Clin Infect Dis. 2018;67:1063–1071.
  • Ladhani SN, Andrews NJ, Southern J, et al. Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. Clin Infect Dis. 2015;61:1637–1644.
  • Amirthalingam G, Campbell H, Ribeiro S, et al. Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction. Clin Infect Dis. 2016;63:S236–S243.
  • Baxter R, Bartlett J, Fireman B, et al. Effectiveness of vaccination during pregnancy to prevent infant pertussis. Pediatrics. 2017;139:e20164091.
  • Ibrahim R, Ali SA, Kazi AM, et al. Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting. Vaccine. 2018;36:7048–7053.
  • Sociedade Brasileira de Imunizações. Calendário de vacinação SBIM prematuro. Recomendações da Sociedade Brasileira de Imunizações (SBIm) – 2018/2019. 2018. [cited 2018 Nov 8]. Available from: https://sbim.org.br/images/calendarios/calend-sbim-prematuro.pdf
  • Ministerio de Salud (Argentina). Recién nacidos prematuros: vacuna séxtuple acelular lineamientos técnicos. 2013. [cited 2018 Nov 8]. Available from: http://www.msal.gob.ar/images/stories/bes/graficos/0000000444cnt-2013-10_lineamientos-sextuple-en-prematuros.pdf
  • World Health Organization. WHO vaccine-preventable diseases surveillance standards: pertussis. 2018. [cited 2019 Mar 20]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/standards/en/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.